Indeed, H2O2-mediated activation of AKT/ERK in CLL cells was completely inhibited upon pretreatment of the cells with a high-affinity AXL inhibitor25 (Fig. 5H). Here, AKT1 is linked to B-cell chronic lymphocytic leukemia.